ALX Oncology Holdings Inc.

Historical 13F Holders

Symbol
ALXO
CUSIP
00166B105
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 00166B105 since 12/18/2024, largest first.

Filer % of Class Filed
venBio Global Strategic Fund, L.P. 13D/A
10.0% 10/16/2026
Event 10/14/2026
RA Capital Management, L.P. 13G
9.9% 2/9/2026
Event 2/2/2026
HBM Healthcare Investments (Cayman) Ltd. 13G/A 6.5% 5/15/2026
Event 3/31/2026
Tang Capital Partners LP 13G/A
6.3% 2/14/2025
Event 12/31/2024
BlackRock, Inc. 13G 5.4% 7/27/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (6)
Redmile Group, LLC 13G/A
6.8%
Checked 5% or less
5/15/2026
Event 3/31/2026
TCG Crossover GP II, LLC 13G/A
4.2% 8/14/2026
Event 6/30/2026
FMR LLC 13G/A
3.4% 12/6/2024
Event 11/29/2024
LSV Associates, LLC 13D/A
2.2% 5/27/2026
Event 5/27/2026
Millennium Management LLC 13G/A
1.5% 4/28/2026
Event 3/31/2026
Tang Capital Management LLC 13G/A
0% 11/14/2025
Event 9/30/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 113 106 M $147M
2026 Q2 94 105 M $218M
2026 Q1 70 94.3 M $189M
2025 Q4 57 29.2 M $33.5M
2025 Q3 62 27.8 M $51.3M
2025 Q2 63 29.1 M $12.6M
2025 Q1 86 34.8 M $22.1M
2024 Q4 89 41.1 M $69.0M
2024 Q3 95 45.5 M $83.1M
2024 Q2 116 48.6 M $293M
2024 Q1 107 45.8 M $510M
2023 Q4 96 45.8 M $681M
2023 Q3 78 33.3 M $160M
2023 Q2 76 34.3 M $258M
2023 Q1 87 35.7 M $161M
2022 Q4 89 36.4 M $411M
2022 Q3 101 36.4 M $349M
2022 Q2 98 35.9 M $291M
2022 Q1 97 36.8 M $622M
2021 Q4 110 36.3 M $780M
2021 Q3 117 34.5 M $2.55B
2021 Q2 106 33.3 M $1.82B
2021 Q1 96 33.5 M $2.47B
2020 Q4 91 32.3 M $2.78B
2020 Q3 58 27.3 M $1.03B